Prevalence and consequences of empiric anticoagulation for venous thromboembolism in patients hospitalized for COVID-19: a cautionary tale

J Thromb Thrombolysis. 2021 Nov;52(4):1056-1060. doi: 10.1007/s11239-021-02471-x. Epub 2021 May 3.
No abstract available

MeSH terms

  • Anticoagulants* / adverse effects
  • COVID-19* / complications
  • Humans
  • Prevalence
  • Venous Thromboembolism* / drug therapy
  • Venous Thromboembolism* / epidemiology

Substances

  • Anticoagulants